NPS MedicineWise has created
a useful dosage guide for the new
range of anticoagulant therapy
for patients suffering from Atrial
Fibrillation (AF), Pulmonary
Embolism (PE) and Venous
ThromboEmbolism (VTE).
It includes a table giving details of
the different contraindications for
each of the newer anticoagulants.
The guide can be used to adjust
dosing depending on the indication
for therapy and the patient’s level
of renal impairment, age and/or
weight.
Rivaroxaban (Xarelto from Bayer)
is flagged for listing on the PBS
from August 01 (PD July 08).
To access the guide CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Jul 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Jul 13
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.